Применение малобелковой диеты для замедления прогрессирования хронической почечной недостаточности

1. Береснева О.Н., Парастаева М.М., Иванова Г.Т. и др. Роль кетостерила в нефропротекции и кардиопротекции при экспериментальной уремии. Нефрология. 2006; 1: 56–62.
2. Тареева И.Е., Кутырина И.М., Николаев А.Ю. и др. Пути торможения развития хронической почечной недостаточности. Тер. архив. 2000; 6: 9–14.
3. Чеботарева Н.В.. Бобкова И.Н., Козловская Л.В. Молекулярные механизмы интерстициального фиброза при прогрессирующих заболеваниях почек. Нефрол. и диал. 2006; 1: 26–36.
4. Agus D, Mann R, Cohn D et al. Inhibitory role of dietary protein restriction on the development and expression of immune mediated antitubular basament membrano-induced tubulointerstitial nephritis in rats. J Clin Investig 1985; 76: 930–6.
5. Ambard L. Physiologie Normale et Phathologie des Reins. Paris: Masson et Cie, 1920.
6. Aparicio M, Potaux L, Precigout V et al. Hypertriglyceridemia and low-phosphorus, low-nitrogen diet in patient with chronic renal failure. Nephron 1987; 46: 335–6.
7. Aparicio M, Bouchet J, Gin H et al. Effect of a low-protein diet on urinary albumin excretion in uremic patients. Nephron 1988; 50: 288–91.
8. Aparicio M, Vincendeau Ph, Gin H et al. Effect of a low-protein diet on chemiluminescence production by leukocytes from uremic patients. Nephron 1988; 48: 315–8.
9. Aparicio M, Gin H, Potaux L et al. Effect of ketoacid diet on glucose tolerance and tissue insulin sensitivity. Kidney Int 1989; 36 (Suppl. 27): 231–5.
10. Aparicio M, Gin H, de Precigout V et al. Complaince with low protein diet by uremic patients: three years' experience. Contrib Nephrol 1990; 81: 71–8.
11. Aparicio M, Lafage MH, Combe C et al. Low-protein diet and renal osteodystrophy. Nephron 1991; 58: 250–2.
12. Aparicio M, Lafage MH, Combe C и др. Метаболические эффекты низкобелковой низкофосфорной диеты у больных с хронической почечной недостаточностью. Клин. фармакол. тер. 1996; 2: 15–8.
13. Avram M, Shreedhara R, Fein P et al. Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters. Am J Kidney Dis 2001; 37: S77–S80.
14. Arai J, Hara Y, Fukuda S et al. Metabolic conversion of a-keto valine to valine in patients with chronic renal failure. Clin Nephrol 1985; 23: 236–40.
15. Barrientos A, Arteaga J, Rodicio L et al. Role of the control of phosphate in the progression of chronic renal failure. Mineral Electrolyte Metab 1982; 7: 127–33.
16. Barsotti G, Morelli E, Guiducci A et al. Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet. Nephron 1982; 30: 310–3.
17. Barsotti G, Morelli E, Cupisti A et al. Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure: a controled trial. Kidney Int 1983; 24 (Suppl. 16): 278–84.
18. Barsotti G, Gainnoni A, Morelli E et al. The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet. Clin Nephrol 1984; 21: 54–9.
19. Barsotti G, Cristofano C, Morelli E et al. Serum oxalis acid in uremia: effect of a low-protein diet supplemented with essential amino acids and ketoanalogues. Nephron 1984; 38: 54–6.
20. Barsotti G, Ciardella F, Morelli E et al. Restoratoin of blood levels of testosterone in male uremics following a low-protein diet supplemented with essential amino acids and ketoanalogues. Contr Nephrol 1985; 49: 63–9.
21. Barsotti G, Ciardella F, Morelli E et al. Nutritional treatment of renal failure in type 1 diabetic nephropathy. Clin Nephrol 1988; 29: 280–7.
22. Barsotti G, Moriconi L, Cupisti A et al. Protection of renal function and nutritional status in uraemic rats by means of a low-protein, low-phosphorus supplemented diet. Nephron 1988; 49: 197–202.
23. Beale L. Kidney diseases, urinary deposits and calculous disorders. There nature and treatment. Philadelphia,-Lindsay and Blakiston, 1869.
24. Beddhu S, Samore M, Roberts M et al. Impact of initiation of dialysis on mortality. J Am Soc Nephrol 2003; 14: 2305–12.
25. Bending J, Dodds R, Keen H et al. Renal response to restriction protein intake in diabetic nephropathy. Diabetologia 1988; 37: 1641–6.
26. Bеrgesio F, Monzani G, Guasparini A et al. Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment. Clin Nephrol 2005; 64: 103–12.
27. Berlyne G, Shaw A, Nilwarngkur S. Dietary treatment of chronic renal failure. Experience with modified Giovannetti diet. Nephron 1965; 2: 129–47.
28. Bernard S, Fongue D, Laville M, Zech P. Effects of low protein diet supplemented with ketoacids on plasma lipids in adult chronic renal failure. Miner Electrolite Metab 1996; 22: 143–6.
29. Blumenkrantz M, Kopple JV. A cooperative dialysis study participants: incidence of nutritional abnormalities in uremic patients entering dialysis therapy. Kidney Int 1976; 10: 514.
30. Bonomini V, Felleti C, Scolary M, Stefani S. Benefits of early initiation of dialysis. Kidney Int 1985; 28 (Suppl. 17): S57–S59.
31. Bradford J. The results following partial nephrectomy and the influence of the kidney metabolism. J Physiol 1899; 23: 415.
32. Brenner B, Meyer T, Hostetter T. Dietary protein intake and the progressive nature of kidney disease: the role hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease. N Engl J Med 1982; 307: 652–9.
33. Brenner B. Hemodynamically mediated glomerular injury and the progressive nature of renal disease. Kidney Int 1983; 23: 647–55.
34. Brenner B. Nephron adaptation to renal injuri or ablation. Am J Physiol 1985; 249: F324.
35. Chade A, Lerman A, Lerman L. Kidney in early atherosclerosis. Hypertension 2005; 45: 1042–9.
36. Chanutin A, Ferris E. Experimental renal insufficiency produced by partial nephrectomy. I Control diet. Arch Int Med 1936; 58: 60.
37. Chauveau Ph, Lebkiri B, Ployard F et al. Effect des cetoanalogues des acides amines essentials sur la progression de l'insuffience renale chronique avancee: etude prospective controlee. Nephrologie 1986; 4: 137–42.
38. Churchull D. An evidence-based approach to earlier initiation of dialysis. Am J Kidney Dis 1997; 30: 899–906.
39. Ciardella F, Morelli E, Niosi F et al. Effect of a low-phosphorus, low nitrogen diet supplemented with essential amino acids and ketoanalogues on serum triglycerides of chronic uremic patients. Nephron 1986; 42: 196–9.
40. Ciardella F, Morelli E, Cupisti et al. Metabolic effects of very low protein low phosphorus diet supplemented with essential amino acids and ketoanaloges in end-stage renal diseases. Contr Nephrol 1988; 65: 72–88.
41. Claris-Appiani A, Assael B, Tirelli A. Lack of glomerular hemodynamic stimulation after infusion of branched-chain amino acids. Kidney Int 1988; 33: 91–4.
42. Cohen D, Dodds R, Viberti G. Effect protein restriction in insulin dependent diabetics at risk of nephropathy. Br Med J 1987; 294: 795–8.
43. Coresh J, Walser M, Hill S. Survival on dialysis among chronic renal failure patients treated with a supplemented low-protein diet before dialysis. J Am Soc Nephrol 1995; 6: 1379–85.
44. Corman B, Chami-Khazraji S, Schaeverbeke J, Michel J. Effect of feeding on glomerular filtration in conscious aging rats. Am J Physiol 1988; 255: F250–6.
45. Cupisti A, Carulli G, Polidori R et al. Superoxide anion prodution and dietary treatment in chronic renal failure. Nephron 1991; 57: 119–20.
46.  Di Iorio B, Minutolo R, De Nicola L et al. Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney Int 2003; 64: 1822–8.
47. El-Nahas A, Masters-Thomas A, Brady S et al. Selective of low protein diet in chronic renal diseases. Brit Med J 1984; 289: 1337–41.
48. Evanoff G, Thompson C, Brown J et al. The effect protein restriction on the progression diabetic nephropathy. A 12-month follow-up. Arch Int Med 1987; 147: 492–5.
49. Fera H. FЯnf Sprachen unter einem Hut. Berlin, Verlage fЯr Volkstum, 1939.
50. Fioretti P, Melis G, Ciardella F et al. Parathyreoid function and pituitary-gonadal axis in male uremics; effects of dietary treatment and of maintenance hemodialysis. Clin Nephrol 1986; 25: 155–8.
51. Fouque D, Wang P, Laville M et al. Low protein diets delay end-stage renal disease in no-diabetic adults with chronic renal failure. Nephrol Dial Trasplant 2000; 15: 1986–92.
52. FrЯhling P, Kokot F, Schmicker R et al. Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure. Clin Nephrol 1983; 20: 212–5.
53. FrЯhling P, Schmidt-Gayk H, Kokot F et al. Influence of vitamin D and keto acids (KA) on 1,25(OH)2D levels in patient with chronic renal failure. Vitamin D: Chem Biochem and Clin Update. Proc 6th workshop., Merano, 17–22 March. Berlin, 1985; 952–3.
54. FrЯhling P, Krupki F, Kokot F et al. What are the most impotant factors in the progression of renal failure? Kidney Int 1989; 36 (Suppl. 27): S106–9.
55. Garibotto Q, Russo R, Sifia A et al. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 1994; 45: 1432–9.
56. Gin H, Aparicio M, Potaux L et al. Low-protein and low phosphorus diet in patients with chronic renal failure: influence on glucose tolerance and tissue insulin sensitivity. Metabolism 1987; 36: 1080–5.
57. Gin H, Aparicio M, Potaux L et al. Low-protein, low-phosphorus diet and tissue insulin sensitivity in insulin-dependent diabetic patients with chronic renal failure. Nephron 1991; 57: 411–5.
58. Gin H, Combe C, Rigallean V et al. Effects of low-protein, low-phosphorus diet on metabolic insulin clearance in patients with chronic renal failure. Am J Clin Nutr 1994; 59: 663–6.
59. Giordano C. The use of exogenous and endogenous urea for protein in normal and uremia subjects. J Lab Clin Med 1963; 62: 231.
60. Giovanetti S, Maggiore Q. A low nitrogen diet with proteins of high biological value for severe chronic uremia. Lancet 1964; 1: 1000–3.
61. Giovanetti S. Unwanted side effects of nutritional therapy for patients with chronic renal failure. In book: Nutritional treatment of chronic renal failure. Kluwer. Oxford, 1989.
62. Glasser R, Velosa J, Michael A. Experimental model of focal sclerosis. Lab Investing 1977; 36: 519–26.
63. Graham K, Reaich D, Channon S et al. Correction acidosis in CAPD descrease whole body protein degradation. Kidney Int 1996; 49: 1396–400.
64. GrЯtzmacher P, MКrz W, Peschke B et al. Lipoproteins and apolipoproteins during progression of chronic renal disease. Nephron 1988; 50: 103–11.
65. Goodship T, Mitch W, Hoerr et al. Adaption to low protein diets in renal failure: turnover and nitrogen balance. J Am Soc Nephrol 1990; 3: 66–75.
66. Haeberie K. Physiological aspects of low protein diet therapy. Blood Purif 1989; 7: 32–42.
67. Hakim R, Lazarus J. Initiation of dialysis. J Am Soc Nephrol 1998; 9: 596–9.
68. Halliburton J, Thomson R. Clinical aspects of compensatory renal hypertrophy. Cancer Res 1965; 25: 1882–7.
69. Hansen H, Tauber-Lassen B, Jensen B et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int 2002; 62: 220–8.
70. Hara Y, May R, Kelly R, Mitch W. Acidosis, not azotemia stimulates branched= chain amino acid catabolism in uremic rats. Kidney Int 1987; 32: 808–14.
71. Harris D, Chan L, Schrier R. Remnant kidney hypermetabolism and progression of chronic renal failure. Am J Physiol 1988; 254: F267–76.
72. Haut L, Alfrey A, Guggenheim S et al. Renal toxicity of phosphate in rats. Kidney Int 1980; 17: 722–31.
73. Heidland A, Kult J. Long-term effects of essential amino acid supplemention in patients on regular dialysis treatment. Clin Nephrol 1975; 3: 235–9.
74. Heifets M, Morrissey J, Purkerson M et al. Effect of dietary lipids on renal function in rats with subtotal nephrectomy. Kidney Int 1989; 35: 40–7.
75. Hirschberg R, Cohen A, Kopple J. Effects of keto acid supplements on renal function and histology in azotemic rats fed heigh-protein diets. Am J Nephrol 1988; 8: 50–5.
76. Ibels L, Alfrey A, Haut L et al. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 1978; 298: 122–6.
77. Ihle B, Becker G, Whitworth J, Charlwood R, Kincaid-Smith P. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 1989; 321: 1773–7.
78. Ikizler T, Green J, Wingard R et al. Spontaneous dietary intake during progression of chronic renal failure. J Am Soc Nephrol 1995; 6: 1386–91.
79. Ikizler T, Pupim L, Bronilette J et al. Hemodialysis stimulate muscle and whole body protein loss and alters substrate oxidation. Am Physiol Endocrinol Metab 2002; 282: E107–16.
80. Ingale A, Ingale F, Kulkarni H. Unexpected rise in GFR in a patient of chronic kidney disease with single functioning kidney following keto-diet: a case report. Am J Nephrol 2004; 24: 61.
81. Ishikava I, Purkerson M, Klahr S et al. Mechanism of reduced glomerular filtration rats in chronic malnutrition. J Clin Investig 1980; 65: 982–8.
82. Ishikava I, Purkerson M, Yates J, Klahr S. Dietary protein intake conditions the degree of renal vasoconstriction in acute renal failure caused by ureteral obstruction. Am J Physiol 1985; 249: F54–7.
83. Jones M, Kopple J. Valine metabolism in normal and chronically uremic man. Am J Clin Nutr 1978; 31: 1660–4.
84. Jungers P, Chauveau Ph, Ployard F et al. Comparision of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney Int 1987; 32 (suppl. 22): S67–S71.
85. Kaysen G. Hyperlipidemia of chronic renal failure. Blood Purif 1994; 12: 60–7.
86.  Kasiske B, Lakatna J, Ma J, Louis T. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31: 954–61.
87. Keane W, Kasiske B, O'Donell M. Hyperlipidemia and the progression of renal disease. Am J Clin Nutr 1988; 47: 157–60.
88. Keane W, Kasiske B, O'Donell M. Lipids and progressive glomerulosclerosis. Am J Nephrol 1988; 8: 261–81.
89. Kenner Ch, Evan A, Bromgren Ph et al. Effect of protein intake on renal function and structure in partially nephroctomized rats. Kidney Int 1985; 27: 739–50.
90. King A, Levey A. Dietary proteins and renal function. JASN 1993; 3: 1723–37.
91. Klahr S, Tripathy K. Evaluation of renal fuction in malnutrition. Arch Int Med 1966; 118: 322–5.
92. Klahr S, Levey A, Beck G et al. The effects of dietary protein restricton and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877–84.
93. Kleinknecht C, Laounari D, Thorel D et al. Protein diet and uremic toxicity: muth or reality? Kidney Int 1987; 32 (Suppl. 22): 62–6.
94. Kopple J, Coburn J, Metabolic studies of low protein diets in uremia: I. Nitrogen and potassium. Medicine 1973; 52: 583–95.
95. Kopple J, Swendseid M. Protein and aminoacid metabolism in uremic patients undergoing maintenance hemodialysis. Kidney Int 1975; 7: S64–72.
96. Kopple J, Monteon F, Shaib J. Effects of energy intake on nitrogen metabolism in nondialysed patients with chronic renal failure. Kidney Int 1986; 22: 48–53.
97. Кopple J, Levey A, Greene T et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease study. Kidney Int 1997; 52: 778–9.
98. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein(a) in renal desease. Am J Kidney Dis 1996; 27: 1–25.
99. Lafage MH, Combe Ch, Fournier A, Aparicio M. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy. Kidney Int 1992; 42: 1217–25.
100. Laouari D, Kleinknecht C, Habib R et al. The roles of phosphorus deficiency and low food intake in the preservation of renal function in uraemic rats. Experientia 1982; 38 (6): 681–2.
101. Laouari D, Kleinknecht C, Broyer M. Utilisation des keto-analoges d'acides amines dans l'insuffisance renale chronique. Nephrologie 1986; 7: 133–7.
102. Laouari D, Rocchiccioli F, Dodu C et al. Conversion of two branched-chain a-ketoanalogs in normal and uremic rats. Kidney Int 1987; 32 (Suppl. 22): S186–90.
103. Lim V, Kopple J. Protein metabolism in patients with chronic renal failure. Role of uremia and dialysis. Kidney Int 2000; 58: 1–10.
104. Lindenau K, Kokot F, Fr?hling T. Supression of parathyroid hormone by therapy with a mixture of keto analogues/amino acidis in hemodialysis patient. Nephron 1986; 43: 84–6.
105. Lindenau K, Abendroth K, Kokot F et al. Therapeutic effect of keto acids on renal osteodystrophy. Nephron 1990; 55: 113–35.
106. Locatelli F, Marselli D, Ponti R et al. Effect of low protein diet on the progression of adult dominant polycystic kidney disease. Seminar on cystic renal disease. Milano 1989; 47–52.
107. Locatelli F, Alberti D, Graziani G et al. Prospective, randomised, multicentre trail of effect of protein restriction on progression of chronic renal insufficiency. Lancet 1991; 337: 1299–304.
108. Loschiavo C, Ferrari S, Panebianco R et al. Effect of protein-restricted diet on serum lipids and atherosclerosis risk factors in patients with chronic renal failure. Clin Nephrol 1988; 29: 113–8.
109. Lucas PA, Brown RC, Woodhead JS et al. 1,25-dihydroxycholecalciferol and parathyroid hormon in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction. Clin Nephrol 1986; 25: 7–10.
110. Lucas Ph. Meadows J, Roberts D et al. The risk and benefits of a low protein-essential amino acid-keto acid diet. Kidney Int 1986; 29: 995–1003.
111. Lumlertgul D, Bruke T, Gillum D et al. Phosphate depletion arrests progression of chronic renal failure independent of protein intake. Kidney Int 1986; 29: 658–66.
112. Maroni B. Protein restriction and malnutrition in renal disease: fact of fiction? Miner Electrolyte Metab 1997; 23: 225–8.
113. Maroni B, Staffeld C, Young V et al. How is lean body mass concerved with the very low protein regimen? Miner Electrolyte Metab 1996; 22: 54–7.
114. Maroni B. Impact of chronic renal failure on nitrogen metabolism. Miner Electrolyte Metab 1998; 24: 34–40.
115. Maschio G, Oldriggi L, Tessitore N et al. Effects of dietary protein and phosphorus restriction on the progression of early renal failure. Kidney Int 1982; 22: 371–6.
116. Masud T, Young V, Charman T et al. Adaptive responses to very low protein diets: the first comparision of keto-acids to essential amino acids. Kidney Int 1994; 45: 1182–92.
117. Mauer S, Steffer M, Asar S et al. The effects of Golblatt hypertension on the development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 1978; 27: 738–44.
118. May R, Hara Y, Kelly R et al. Branched chain amino acid metabolism in rat muscle: Abnormal regulation in acidosis. Am J Physiol 1987; 252: E712–8.
119. Meisinger E, Strauch M. Controlled trial of two ketoacid supplements on renal function, nutritional status and bone metabolism in uremic patients. Kidney Int 1987; 32 (Suppl. 22): S170–3.
120. Mitch W, Walser M, Sapir D. Nitrogen sparing induced by leucine compared with that induced by its keto-analogue, alpha-ketoisocaproate in fasting obese man. J Clin Investing 1981; 67: 553–62.
121. Mitch W, Steinman T, Walser M. The effect of protein restriction plus ketoacids on progression of chronic renal failure. Clin Res 1983; 31: 437.
122. Mitch W, Clark A. Specifity of the effect of leucini and its metabolites on protein degradation in skeletal muscle. Biochem J 1984; 222: 579–86.
123. Mitch W. Dietary protein restriction and progressive renal insufficiency. Am J Kidney Dis 1997; 30 (2): 297–300.
124. Monzani G, Bergegio F, Ciuti R et al. Lp(a) levels: effects of progressive chronic renal falure and dietary management. J Nephrol 1997; 10: 41–5.
125. Nanra R, Kelson K. Chronic renal failure (CRF) diet withhout amino acid (AA) supplements in progressive renal disease: a controlled trial. Kidney Int 1989; 35: 737.
126. Nath K, Hostetter M, Hostetter T. Ammonia-complement interaction in the pathogenesis progressive renal injury. Kidney Int 1989; 36 (Suppl. 27): S52–4.
127. Nelson P, Shankland S. Therapeutics in renal disease: the road ahead for antiproliferaferative targets. Nephron 2006; 103: e6–e15.
128. NKF-K/DOQI Clinical Practice Guideline for Nutrition in Chronic Renal Failure. Am J Kidney Dis 2000; 35 (Suppl. 2): 60–1.
129. Obrador G, Arora P, Kausz et al. Pre-end stage disease care in the United States: a state of disrepair. J Am Soc Nephrol 1998; 9: S44–54.
130. Oldrizzi L, Rugiu C, Valvo E et al. Progression of renal failure in patients with renal diseases of diverse etiology on protein-restricted diet. Kidney Int 1985; 27: 553–7.
131. Paradodoyaunakis N, Stefanides C, Patricarea A at al. The effect of calcium carbonate administration on nitrogen metabolism in patients on hemodialysis. Proc EDTA 1985; 22: 83–7.
132. Pedrini M, Levey A, Lau J et al. The effect dietary restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 1996; 124: 627–32.
133. Peuchant E, Delmas-Beauvieux M, Dubourg L et al. Antioxidant effects of supplemented very low protein diet in chronic renal failure. Free Radical Biol Med 1997; 22: 313–20.
134. Prakash S, Pande D, Sharma S et al. Randomized, double-blind, placebo-controlled trial to evaluate effecacy to ketodiet in predialytic chronic renal failure. J Renal Nutr 2004; 14: 86–96.
135. Rose W. Amino acid requirements in man. Fed Proc 1949; 8: 546–2.
136. Rosman J, Meijer S, Sluiter W et al Prospective randomized trial of early dietary protein restriction in chronic renal failure. Lancet 1984; II: 1291–5.
137. Rosman J, ter Wee P. Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purif 1989; 7: 52–7.
138. Schaefer K, Herrath D, Asmus G et al. The beneficial effect of ketoacids on serum phosphate and parathyroid hormone in patient with chronic uremia. Clin Nephrol 1988; 30 (2): 93–6.
139. Schaefer K, Erley C, von Herrath D, Stein G. Calcium salts of ketoacid as a new treatment strategy for uremic hyperphosphatemia. Kidney Int 1989; 36 (Suppl. 27): S136–9.
140. Seifart G, Ensminger A, Scholz R. Increase in body mass during long term bicarbonate dialysis. Kidney Int 1987; 31 (Suppl. 22): 174–7.
141. Seyer-Hansen, Hansen J, Gundersen H. Renal hypertrophy in experimental diabetes: a morphometric study. Diabetologia 1980; 18: 501–5.
142. Smadel J, Farr L. The effect of diet on the pathological changes in rats with nephrotoxic nephritis. Am J Physiol 1939; 13: 199–221.
143. Steffes M, Brown D, Maucr S. Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 1978; 27: 35–41.
144. Teoduoru C, Saifer A, Frankel H. Conditioning factors influence evolution of experimentul glomerulonephritis in rabbits. Am J Physiol 1954; 193: 457–60.
145. Teplan B, SchЯck O, Horanova M, Skibova J. Effect of ketoacid-amino supplement on the metabolism and renal elimination of branched chain amino acids in patients with chronic renal insufficiency on low protein diet. Wien Klin Wschr 2000; 112: 876–81.
146. Teplan B, SchЯck O, Votrula M et al. Metabolic effects of keto acid-amino acid supplementation in patients with chronic renal insufficiency receiving a low protein diet and recombinant human erythropoietin-randomized controlled trial. Wien Klin Wschr 2001; 113: 661–9.
147. Tom K Young V, Charman T et al. Long-term adaptive responses to low protein diet in chronic renal failure. Am J Physiol 1995; 268: F668–77.
148. Traynor J, Simpson K, Geddes C et al. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002; 13: 2125–32.
149. Trevino-Bessera A, Lopez J, Alanis L. Ketoanalogues and a very-low-protein diet diminism serum cholesterol in predialysis patients. Dialy Transplant 2002; 31: 25–6.
150. Tungsanga K, Kang Ch, Walser M. Utilisation of alpha-ketoisocaproate for protein synthesis in uremic rats. Kidney Int 1986; 30: 891–4.
151. United States Renal Date System: The USRDS: Morbidity and Mortality Study Wave 2. Am J Kidney Dis 1997; 30 (Suppl. 1): S67–8.
152. Venderly B, Chauveau P, Barthe N et al. Nutrition in hemodialysis patients previously on a supplemented very low protein diet. Kidney Int 2003; 63: 1491–8.
153. Verberckmoes R, Van Rerterghem Y. Can the effects of protein restriction on the progression of renal failure also be achieved by pharmacological means? Blood Purif 1989; 7: 58–60.
154. Volhard F. Die doppelseitigen hКmatogenen Nierenerkrankungen (Bright'sche Krankheit). Handbuсh der inneren Medezin, Berlin, Springer, 1918; S. 1149–72.
155. Walker W, Gimenez L, Tew W et al. Prevention of phosphate induced progression of experimental uremia by 3-phosphocitric acid. Proc. 5-th Int. Workshop "Phosphate and other Miner". London 1982; 157–66.
156. Walser M, La France D, Ward L, Van Duym M. Progression of chronic renal failure in patients given ketoacids following amino acid. Kidney Int 1987; 32: 123–8.
157. Walser M. Dietary proteins and their relationship to kidney disease. Dietary proteins in health and disease 1992; 168–78.
158. Walser M. Does prolonged protein restriction preceding dialysis lead to protein malnutrition at the onset of dialysis? Kidney Int 1993; 44: 1139–44.
159. Walser M, Hill S. Can renal replacement be deferred by a supplemented very low protein diet. J Am Soc Nephrol 1999; 10: 110–6.
160. Walser M, Mitch W, Maroni B et al. Should protein intake be restricted in predialysis patients? Kidney Int 1999; 55: 771–7.
161. Walser M. In there a role for protein restriction in the treatment of chronic renal failure? Blood Purif 2000; 18: 304–12.
162. Walter F, Addis T. Organ work and organ weight. J Exp Med 1939; 69: 467–83.
163. Williams B, Hattersley J, Layward E, Walls J. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronical uremia. Kidney Int 1991; 40: 779–86.
164. Wiserman M, Bogneetti E, Dodds R et al. Changes in renal failure in response to protein restriction diet in type 1 (insulin dependent) diabetic patients. Diabetologia 1987; 30: 154–9.
165. Yong G, Keogh J, Parsons F. Plasma amino acids and protein levels in chronic renal failure and changes caused by oral supplemention of essential amino acid. Clin Chim Acta 1975; 61: 205–13.
166. Yoshida Y, Fogo A, Ichicava I. Glomerular hypertrophy has a great impact on glomerular sclerosis than adaptive hyperperfusion in remnant nephrons. Kidney Int 1988; 33: 327.
167. Zakar G. The effect of keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular dialysis theraphy: the Hungarian ketosteril cohort study. Wien Klin Wschr 2001; 113: 688–94.
168. Zatz R, Meyer T, Rennke H, Brenner B. Predominance of hemodynamic rather than methabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985; 82: 5963–7.